Filter
1506
Filtered Results: 1506
Text search:
drug
approval
Featured
Recommendations
105
New Publications
446
Language
Document type
No document type
913
Studies & Reports
253
Guidelines
186
Manuals
64
Strategic & Response Plan
35
Fact sheets
28
Training Material
15
Situation Updates
5
Resource Platforms
4
Infographics
2
Brochures
1
Countries / Regions
India
99
Kenya
47
Uganda
46
Global
42
Nigeria
39
South Africa
37
Malawi
35
Ethiopia
32
Nepal
32
Sierra Leone
30
Western and Central Europe
29
Myanmar / Burma
26
Liberia
25
Ukraine
25
Ghana
24
Bangladesh
24
Zambia
23
Tanzania
22
Rwanda
19
Latin America and the Carribbean
19
Namibia
17
Lesotho
17
Africa
15
Zimbabwe
14
South–East Asia Region
13
Eastern Europe
12
Botswana
11
Congo, Democratic Republic of
10
Burkina Faso
9
Senegal
8
Philippines
8
Cambodia
8
Asia
8
Syria
6
Thailand
6
Tajikistan
6
Russia
6
USA
5
Pakistan
5
Mozambique
5
Benin
5
Cameroon
4
South Sudan
4
Germany
4
China
4
Indonesia
4
Peru
4
East and Southern Africa
4
Venezuela
4
Albania
4
Afghanistan
3
Eswatini/ Swaziland
3
West and Central Africa
3
Eastern Europe and Central Asia
3
Georgia
3
Vietnam
3
Guinea
2
Somalia
2
Iraq
2
Central African Republic
2
Brazil
2
El Salvador
2
Mexico
2
Middle East and North Africa
2
Western Pacific Region
2
Bhutan
2
Laos
2
Moldova
2
Jamaica
2
Haiti
1
Lebanon
1
Turkey
1
Sudan
1
Argentina
1
Colombia
1
Libya
1
Madagascar
1
Sri Lanka
1
Chile
1
Yemen
1
Paraguay
1
Fiji
1
Palestine
1
Armenia
1
Southern Africa
1
Qatar
1
Iran
1
Uzbekistan
1
Kyrgyzstan
1
Australia
1
Kazakhstan
1
Turkmenistan
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
662
Clinical Guidelines
127
Public Health
52
Women & Child Health
41
Pharmacy & Technologies
36
Key Resources
26
Capacity Building
12
Toolboxes
HIV
179
TB
142
AMR
111
COVID-19
82
Mental Health
79
Pharmacy
71
NTDs
42
Ebola
29
NCDs
28
Rapid Response
26
Caregiver
25
Planetary Health
17
Conflict
13
Global Health Education
13
Refugee
12
Health Financing Toolbox
12
Disability
11
Polio
6
Zika
6
Natural Hazards
5
Specific Hazards
4
Cholera
2
Social Ethics
1
The primary audience of these recommendations includes healthcare providers who are responsible for developing national and local health protocols (particularly those related to hypertensive disorders of pregnancy), and those directly providing care to pregnant women and their newborns, including mi...
This document is based on currently available scientific evidence on treatment for drug use disorders and sets out a framework for the implementation of the Standards, in line with principles of public health care. The Standards identify major compo...
NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME
Revised National Tuberculosis Control Programme
UN, international agencies and experts released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance crisis.
If no action is taken - warns the UN Ad hoc Interagency Coordin...
Available in English, French, Spanish, Russian, Chinese, Arabic and Portugues
Policy brief. July 2020
Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
The term "Programmatic Management of ... Resistant TB" (PMDT) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases.
Int. J. Mol. Sci. 2017, 18, 341, 1 - 10
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for rapid parasite reduction with a partner ... to ensure complete cure. However, resistance to antimalarial drugs, where parasites survive standard doses, threatens malaria control.
Meeting Report 27-29 October 2020
The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ...
